Financing, Equity Capital Markets
New Amsterdam Pharma N.V.
02/24
|
$201.5 Million
![New Amsterdam Pharma N.V.](/sites/default/files/images/custom/new_amsterdam_pharma_n.v._slide_1_image.jpg)
Piper Sandler served as bookrunner for New Amsterdam Pharma N.V. on a confidentially marketed follow-on offering